Form 8-K - Current report:
SEC Accession No. 0001193125-25-019411
Filing Date
2025-02-04
Accepted
2025-02-03 18:12:12
Documents
14
Period of Report
2025-01-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d925667d8k.htm   iXBRL 8-K 31884
  Complete submission text file 0001193125-25-019411.txt   219185

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA prgo-20250129.xsd EX-101.SCH 4898
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prgo-20250129_def.xml EX-101.DEF 15771
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE prgo-20250129_lab.xml EX-101.LAB 26541
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prgo-20250129_pre.xml EX-101.PRE 16859
16 EXTRACTED XBRL INSTANCE DOCUMENT d925667d8k_htm.xml XML 10801
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address THE SHARP BUILDING HOGAN PLACE DUBLIN 2 L2 D02 TY74 269-673-8451
PERRIGO Co plc (Filer) CIK: 0001585364 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36353 | Film No.: 25584136
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)